Burden of Episodic Migraine, Chronic Migraine, and Medication Overuse Headache in Alberta
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2024
DOI: 10.1017/cjn.2023.289 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2024. Verfasst von Suzanne McMullen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medlior Health Outcomes Research Ltd., Calgary, AB, Canada. Hauptthemen laut MEDLINE: Migraine Disorders, Headache Disorders, Secondary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To describe demographic and clinical characteristics, healthcare resource use, costs, and treatment patterns in three migraine cohorts.
Methods
This retrospective observational study using administrative data examined patients with episodic migraine (EM), chronic migraine (CM) (without medication overuse headache [MOH]), and medication overuse headache in Alberta, Canada. Migraine patients were identified between 2012 and 2018 based on ≥ 1 diagnostic codes or triptan prescription. Patients with CM were defined using parameter estimates of a logistic regression model, and MOH was defined as patients with an average of ≥ 15 supply days covered of acute medications. EM was defined as patients without CM or MOH. Study outcomes were summarized using descriptive statistics.
Results
Patients with EM (n = 144,574), CM (n = 27,283), and MOH (n = 11,485) were included. Higher rates of healthcare use and costs were observed for CM (mean [SD] all-cause cost: ($12,693 [40,664]) and MOH ($16,611.5 [$38,748]) versus episodic migraine ($4,251 [$40,637]). Across all cohorts, opioids were the most dispensed acute medication (range across cohorts: 31.7%–89.8%), while antidepressants and anticonvulsants were the most dispensed preventive medication. Preventative medication classes were used by a minority of patients in each cohort, except anticonvulsants, where 50% of medication overuse patients had a dispensation.
Conclusions
Patients with CM and MOH have a greater burden of illness compared to patients with EM. The overutilization of acute medication, particularly opioids, and the underutilization of preventive medications highlight an unmet need to more effectively manage migraine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medlior Health Outcomes Research Ltd., Calgary, AB, Canada.
- Lundbeck Canada Inc.Montreal, QC, Canada.
- Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
ORCID-Profile: Erin Graves, Tram Pham
Zitieren
APA
McMullen, S., Graves, E., Ekwaru, P., Pham, T., Mayer, M., Ladouceur, M. P., Hubert, M., Bougie, J., & Amoozegar, F. (2024). Burden of Episodic Migraine, Chronic Migraine, and Medication Overuse Headache in Alberta. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/cjn.2023.289
Vancouver
McMullen S, Graves E, Ekwaru P, Pham T, Mayer M, Ladouceur MP, et al. Burden of Episodic Migraine, Chronic Migraine, and Medication Overuse Headache in Alberta. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2024. doi:10.1017/cjn.2023.289
BibTeX
@article{McMullen2024,
author = {McMullen, Suzanne and Graves, Erin and Ekwaru, Paul and Pham, Tram and Mayer, Michelle and Ladouceur, Marie-Pier and Hubert, Martine and Bougie, Joanna and Amoozegar, Farnaz},
title = {Burden of Episodic Migraine, Chronic Migraine, and Medication Overuse Headache in Alberta},
journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
year = {2024},
doi = {10.1017/cjn.2023.289}
}
EUVIMED